Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is Depomed Inc (DEPO) Going to Burn These Hedge Funds?

How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly-traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on and going from there. Hedge funds and other institutional investors usually invest large amounts of capital and have to conduct due diligence while choosing their next stock pick. They don’t always get it right, but, on average, their stock picks historically generate strong returns after adjusting for known risk factors. With this in mind, let’s take a look at the recent hedge fund activity surrounding Depomed Inc (NASDAQ:DEPO).

Worst States for Doctors to Practice Medicine


Is Depomed Inc (NASDAQ:DEPO) going to take off soon? Hedge funds are getting more bullish. The number of long hedge fund positions moved up by ten in recent months.

Follow Assertio Therapeutics Inc (NASDAQ:ASRT)
Trade (NASDAQ:ASRT) Now!

In the eyes of most market participants, hedge funds are viewed as unimportant, outdated investment tools of the past. While there are more than 8,000 funds trading today, Insider Monkey looks at only the crème de la crème of this club, approximately 700 funds. It is estimated that this group of investors command the bulk of the smart money’s total asset base, and by tailing their top picks, Insider Monkey has come up with a number of investment strategies that have historically outpaced Mr. Market. Insider Monkey’s small-cap hedge fund strategy beat the S&P 500 index by 12 percentage points per year for a decade in its back tests.

With all of this in mind, we’re going to take a peek at the fresh action regarding Depomed Inc (NASDAQ:DEPO).

How are hedge funds trading Depomed Inc (NASDAQ:DEPO)?

At the end of the third quarter, a total of 32 of the hedge funds tracked by Insider Monkey held long positions in this stock, an increase of 45% from one quarter earlier. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few key hedge fund managers who were increasing their holdings significantly.

According to hedge fund intelligence website Insider Monkey, Richard Mashaal’s Rima Senvest Management had the most valuable position in Depomed Inc (NASDAQ:DEPO), worth close to $51.9 million, comprising 3.7% of its total 13F portfolio. The second-most bullish hedge fund manager was TIG Advisors, led by Carl Tiedemann and Michael Tiedemann, holding a $48.5 million position; the fund had 2.2% of its 13F portfolio invested in the stock. Remaining peers that were bullish contained Thomas Steyer’s Farallon Capital, Matthew Mark’s Jet Capital Investors, and Curtis Schenker and Craig Effron’s Scoggin.

As industrywide interest jumped, some big names have jumped into Depomed Inc (NASDAQ:DEPO) headfirst. TIG Advisors initiated the most outsized position in Depomed Inc (NASDAQ:DEPO) through the aforementioned holding. Farallon Capital made a $30.3 million investment in the stock during the quarter. The following funds were also among the new DEPO investors: Jet Capital Investors, Scoggin, and Alec Litowitz and Ross Laser’s Magnetar Capital.

Let’s also take a look at hedge fund activity in other stocks similar to Depomed Inc (NASDAQ:DEPO). These stocks are MRC Global Inc (NYSE:MRC), AVG Technologies NV (NYSE:AVG), Acorda Therapeutics Inc (NASDAQ:ACOR), and CYS Investments Inc (NYSE:CYS). This group of stocks’ market caps are similar to DEPO’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
MRC 24 332103 -3
AVG 20 92654 -2
ACOR 17 203130 1
CYS 8 5038 0

As you can see, Depomed is quite a bit more popular than its peers and investors are overweight the stock, holding 23.30% of its common shares. Coupled with soaring sentiment, Depomed is certainly a stock that smart money is high on at the moment, which could indicate near-term tailwinds.

With the returns exhibited by the aforementioned tactics, everyday investors must always monitor hedge fund sentiment, and Depomed Inc (NASDAQ:DEPO) applies perfectly to this mantra.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.